ULTRAGENYX PHARMACEUTICAL INC earnings per share and revenue

RARE earnings per share for the last quarter are -33.64 MXN whereas the estimation was -28.96 MXN which accounts for -16.19% surprise. Företagets omsättning för samma period uppgår till 1.80 B MXN trots den uppskattade siffran 1.92 B MXN. Estimated earnings per share for the next quarter are -28.50 MXN, and revenue is expected to reach 2.09 B MXN. Also watch annual changes over time to get a bigger picture of RARE earnings per share and revenue dynamics.